Chest Drain Insertion Assisted by Virtual Reality
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Virtual Reality Headset.
- Who it may be relevant to
- Registry conditions: Pneumothorax Spontaneous Primary, Pneumothorax Spontaneous Secondary, Pleural Effusion. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Drainage Thoracique Assisté Par Un Casque De Réalité Virtuelle
Overview
Clinical study aiming to investigate the potential benefit of the use of virtual reality helmet as a distractor during chest drain insertion to alleviate patients\' pain and anxiety
Interventions
- Device Virtual Reality Headset
A virtual reality headset will be placed on patients\' head before and during chest drain insertion
Primary outcome measures
- Pain - Chest drain [Time frame: During chest drain insertion]
Secondary outcome measures (5)
- Pain - Antalgic consumption [Time frame: during the 24 hours after chest drain insertion]
- Pain - 30 minutes [Time frame: 30 minutes after chest drain insertion]
- Anxiety - Chest drain [Time frame: During chest drain insertion]
- Anxiety - 30 minutes [Time frame: 30 minutes after chest drain insertion]
- feasibility [Time frame: During chest drain insertion]
Eligibility criteria
Inclusion criteria
- Indication of chest drain insertion for pleural effusion or primary spontaneous pneumothorax
- Patient who received clear and loyal information abotu the study protocol
- Patient who consented to participate to the study
- Patient aged 18 years old or older
- Patient affiliated to the french health system
Exclusion criteria
- Patient aged less than 18 years old
- Patient in emergency situation
- Patient with severe heart condition
- Patient allergic to silicone
- Patient with severe psychiatric or mental disorder
- patient with binocular vision anomaly
- patient with pacemaker or defibrillator
- patient wearing a hearing aid that cannot be removed
- Patients under the influence of alcohol or drugs, nausea, fatigue, emotional or anxiety disorders, migraine, headaches, infectious disease
- Patient with past medical history of epilepsia or convulsion
\-- Persons covered by articles L. 1121-5 and L1121-8 of the French Public Health Code:
- Pregnant, parturient or breast-feeding women,
- Persons of full age subject to a legal protection measure (guardianship, curatorship, safeguard of justice)
- adults unable to give their consent
- Persons deprived of their liberty by a judicial or administrative decision, persons under psychiatric care under articles L. 3212-1 and L. 3213-1.
- Person able to give consent but unable to write
- Person able to give consent but unable to read French
- Patient unable to consent to the study
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
Center list to be confirmed — check the primary protocol.
Publications
- Indovina P, Barone D, Gallo L, Chirico A, De Pietro G, Giordano A. Virtual Reality as a Distraction Intervention to Relieve Pain and Distress During Medical Procedures: A Comprehensive Literature Review. Clin J Pain. 2018 Sep;34(9):858-877. doi: 10.1097/AJP.0000000000000599. PMID 29485536
- Perenic E, Grember E, Bassard S, Koutlidis N. Impact of virtual reality on pain management in transrectal MRI-guided prostate biopsy. Front Pain Res (Lausanne). 2023 Oct 2;4:1156463. doi: 10.3389/fpain.2023.1156463. eCollection 2023. PMID 37854306
Identifiers
NCT: NCT06589739 · 2024-A01192-45